{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T19:28:23Z","timestamp":1781983703597,"version":"3.54.5"},"reference-count":27,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2023,8,28]],"date-time":"2023-08-28T00:00:00Z","timestamp":1693180800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Chem Biol Drug Des"],"published-print":{"date-parts":[[2023,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Fangji Huangqi Tang (FHT) is a well\u2010known Chinese herbal formula that is prescribed as treatment for rheumatoid diseases. In this study, we aimed to investigate the potential therapeutic targets, efficacy, and safety of FHT in the treatment of Sjogren's syndrome (SS). The Gene Expression Omnibus (GEO) database was used to screen differentially expressed genes (DEGs) in SS. Further, gene ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analyses were performed to explore the potential biological functions of the DEGs. Subsequently, an FHT\u2010herb\u2010active compound\u2010target network was constructed to identify the relationship between the active compounds in FHT and the related targets. Then, enrichment analysis involving the DEGs and protein\u2013protein interaction (PPI) network analysis were performed to analyze the biological functions of potential targets and screen hub genes. Further, molecular docking was employed to verify the binding affinity between the active compounds and the hub targets, and in vivo experiments involving NOD\/LtJ mice were conducted to verify the therapeutic effects of FHT on SS\u2010like symptoms. Finally, inhibition of PIK3CK\/Akt pathway by FHT was validated by WB and rt\u2010qPCR. A total of 1836 DEGs were identified in SS based on the GSE159574 dataset, and 114 targets of the active compounds in FHT were screened. Further, via network pharmacology analysis and molecular docking, six active compounds and five hub targets were obtained, and enrichment analysis showed that the anti\u2010SS effect of FHT was predominantly associated with immune cells, such as T cells and neutrophils. In vivo, FHT effectively reduced lymphocyte infiltration foci, increased saliva flow rate, and inhibited increases in the levels of SS\u2010related autoantibodies (anti\u2010SSA and anti\u2010SSB). Furthermore, the biosafety of FHT was verified via the serological examination of liver and kidney function. WB and rt\u2010qPCR analysis confirmed that FHT could inhibit the expression of PIK3CG and the activation of PIK3CG\/Akt pathway. Via network pharmacological analysis, molecular docking, and in vivo verification, we demonstrated the multicomponent and multitarget characteristics of FHT in SS treatment, thereby providing novel insights into the pathogenesis of SS and the therapeutic targets of FHT for SS.<\/jats:p>","DOI":"10.1111\/cbdd.14334","type":"journal-article","created":{"date-parts":[[2023,8,29]],"date-time":"2023-08-29T01:40:11Z","timestamp":1693273211000},"page":"1435-1447","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Identification of Fangji Huangqi Tang as a potential herbal formula for Sjogren syndrome treatment via network pharmacology and experimental validation"],"prefix":"10.1111","volume":"102","author":[{"given":"Yanxiong","family":"Shao","sequence":"first","affiliation":[{"name":"Department of Stomatology Shanghai East Hospital, School of Medicine, Tongji University  Shanghai China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Stomatology Shanghai East Hospital, School of Medicine, Tongji University  Shanghai China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaohai","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Stomatology Shanghai East Hospital, School of Medicine, Tongji University  Shanghai China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Plastic Surgery Shanghai East Hospital, School of Medicine, Tongji University  Shanghai China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guojun","family":"Miao","sequence":"additional","affiliation":[{"name":"Department of Stomatology Shanghai East Hospital, School of Medicine, Tongji University  Shanghai China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaoran","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Stomatology Shanghai East Hospital, School of Medicine, Tongji University  Shanghai China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Stomatology Shanghai East Hospital, School of Medicine, Tongji University  Shanghai China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yubo","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Stomatology Shanghai East Hospital, School of Medicine, Tongji University  Shanghai China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2023,8,28]]},"reference":[{"key":"e_1_2_10_2_1","doi-asserted-by":"publisher","DOI":"10.1080\/1744666X.2019.1649596"},{"key":"e_1_2_10_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2021.114615"},{"issue":"9","key":"e_1_2_10_4_1","first-page":"1069","article-title":"Equivalent dose conversion between animals and between animals and humans in pharmacology tests","volume":"9","author":"Huang J.","year":"2014","journal-title":"Chinese Journal of Clinical Pharmacy and Therapeutics"},{"key":"e_1_2_10_5_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12016-007-8012-7"},{"key":"e_1_2_10_6_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature19834"},{"key":"e_1_2_10_7_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2012-202863"},{"key":"e_1_2_10_8_1","doi-asserted-by":"publisher","DOI":"10.3390\/molecules24061154"},{"key":"e_1_2_10_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2018.04.053"},{"key":"e_1_2_10_10_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2019.01261"},{"key":"e_1_2_10_11_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jcim.1c00135"},{"key":"e_1_2_10_12_1","volume-title":"Guide for the care and use of laboratory 340 animals","author":"National Research Council (US) Committee for the Update of the Guide for the Care and Use of Laboratory Animals","year":"2011"},{"key":"e_1_2_10_13_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10238-021-00728-6"},{"key":"e_1_2_10_14_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-014-3051-x"},{"key":"e_1_2_10_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2015.09.006"},{"key":"e_1_2_10_16_1","first-page":"247","article-title":"The epidemiology of Sj\u00f6gren's syndrome","volume":"6","author":"Patel R.","year":"2014","journal-title":"Clinical Epidemiology"},{"key":"e_1_2_10_17_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2019-216114"},{"key":"e_1_2_10_18_1","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2018-000789"},{"key":"e_1_2_10_19_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2016.100"},{"key":"e_1_2_10_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2018.12.043"},{"key":"e_1_2_10_21_1","doi-asserted-by":"publisher","DOI":"10.2174\/1874467215666220217103233"},{"key":"e_1_2_10_22_1","doi-asserted-by":"publisher","DOI":"10.3109\/08916939508995294"},{"key":"e_1_2_10_23_1","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gku1003"},{"key":"e_1_2_10_24_1","doi-asserted-by":"publisher","DOI":"10.1111\/joim.13451"},{"key":"e_1_2_10_25_1","doi-asserted-by":"publisher","DOI":"10.1017\/erm.2018.3"},{"key":"e_1_2_10_26_1","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/4808303"},{"key":"e_1_2_10_27_1","doi-asserted-by":"publisher","DOI":"10.1089\/omi.2011.0118"},{"issue":"06","key":"e_1_2_10_28_1","first-page":"511","article-title":"Discussion on the treatment of bi syndrome with Fangji decoction in synopsis of Golden chamber and its application in later generations","volume":"28","author":"Zhao T.","year":"2018","journal-title":"Zhejiang Journal of Integrated Traditional Chinese and Western Medicine"}],"container-title":["Chemical Biology &amp; Drug Design"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/cbdd.14334","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,8]],"date-time":"2023-11-08T12:22:08Z","timestamp":1699446128000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/cbdd.14334"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,28]]},"references-count":27,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["10.1111\/cbdd.14334"],"URL":"https:\/\/doi.org\/10.1111\/cbdd.14334","archive":["Portico"],"relation":{},"ISSN":["1747-0277","1747-0285"],"issn-type":[{"value":"1747-0277","type":"print"},{"value":"1747-0285","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,28]]},"assertion":[{"value":"2023-07-07","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-08-14","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-08-28","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}